Reed Smith advised Bioventus on the sale. Bioventus Inc. (Nasdaq: BVS) announced that it signed a definitive agreement to sell its Wound business, including the skin...
LifeNet Health’s $85 Million Acquisition of Bioventus’ Wound Business
IDEX’s $120 Million Acquisition of Nexsight
Reed Smith represented Nexsight in the transaction. As part of the definitive agreement, IDEX will acquire Nexsight’s market-leading businesses, including Envirosight, WinCan, MyTana, and Pipeline Renewal...